Market Update (NYSE:ACT): The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF

[Zacks] – The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF Read more on this. Actavis plc (ACT), valued at $70.33B, . . . → Read More: Market Update (NYSE:ACT): The Zacks Analyst Blog Highlights: Actavis, Allergan, iShares U.S. Pharmaceuticals ETF, Market Vectors Pharmaceutical ETF and SPDR S&P Pharmaceuticals ETF Similar Articles: Market Update (NYSE:ACT): Actavis Names Maria Teresa Hilado Chief Financial Officer Market Update (NYSE:ACT): Actavis to Acquire Durata Therapeutics, Inc. Company Update (NYSE:ACT): Actavis to Present at Morgan Stanley Global Healthcare Conference 2014